Provided by Tiger Trade Technology Pte. Ltd.

CH BIOTECH SER

0.615
+0.0050.82%
Volume:65.00K
Turnover:39.25K
Market Cap:600.07M
PE:-8.72
High:0.615
Open:0.600
Low:0.600
Close:0.610
52wk High:1.180
52wk Low:0.300
Shares:975.73M
HK Float Shares:975.73M
Volume Ratio:0.03
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.070
ROE:-14.96%
ROA:-7.46%
PB:2.77
PE(LYR):-8.72
PS:6.99

Loading ...

China Biotech Services Expands Global Reach: New Cross-Border Referral Network Brings BNCT Cancer Therapy to International Patients

Stock News
·
Sep 03

China Biotech Services Signs Cross-Border BNCT Clinical Services Cooperation Pact with OncoCare

Reuters
·
Sep 03

CH BIOTECH SER (08037) Signs Collaborative Accord Linking Hainan Boron Neutron Facility with Hong Kong Cancer Centre

Stock News
·
Sep 03

China Biotech Services Signs One-Year Framework with Tamarind Health’s OncoCare to Channel Overseas Patients to Hainan BNCT Hospital

Bulletin Express
·
Sep 03

China Biotech Services - Pengbo (Hainan) Bnct Hospital Enters Cooperation Agreement with Oncocare on Sept 2, 2026

THOMSON REUTERS
·
Sep 03

China Biotech Services Holdings Ltd - Cooperation Agreement in Relation to Cross-Border Bnct Clinical Services

THOMSON REUTERS
·
Sep 03

China Biotech Services Reports Stable Share Base; 455 Million Shares Potentially Dilutive from Outstanding USD 41 Million Convertible Bonds

Bulletin Express
·
Sep 01

China Biotech Services Holdings Turns Profitable in First Half with HK$18.23 Million Net Gain

Stock News
·
Aug 29

China Biotech Services Swings to FY26 H1 Profit of HK$ 15.06 Million; Revenue Rises 49.7% to HK$ 37.23 Million

Reuters
·
Aug 28

China Biotech Services - Revenue from Cont Ops for Six Months Ended June 30, 2026 Hk$37.23 Mln

THOMSON REUTERS
·
Aug 28

China Biotech Services Holdings Ltd - Hy Profit Attributable Hk$18.2 Mln

THOMSON REUTERS
·
Aug 28

China Biotech Services Holdings Ltd - Board Has Resolved not to Declare Any Dividend for Period Ended 30 June 2026

THOMSON REUTERS
·
Aug 28

China Biotech Services Completes Disposal of PHC and PMS, Accelerates Pivot to BNCT Platform

Bulletin Express
·
Aug 13

China Biotech Services Completes Sale of PHC Medical Diagnostic Centre, Premier Medicare Services Shares

Reuters
·
Aug 13

China Biotech Services Expects H1 Net Profit of at Least HK$15 Million, Swings from Loss

Reuters
·
Aug 12

China Biotech Services forecasts ≥ HK$15.00 million interim profit, reversing prior HK$37.00 million loss on convertible-bond revaluation gains

Bulletin Express
·
Aug 12

China Biotech Services Schedules 28 Aug 2026 Board Meeting to Review 1H26 Results and Potential Dividend

Bulletin Express
·
Aug 12

China Biotech Services - Expects Net Profit of not Less than Hk$15.0 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 12

China Biotech Services - Expected Hy Net Profit Mainly Due to Fair Value Gain on Convertible Bonds of HK$77-87 Mln

THOMSON REUTERS
·
Aug 12

China Biotech Services - Stella Pharma Grants Exclusive Royalty-Free License to Co to Develop Steboronine in the PRC

THOMSON REUTERS
·
Aug 12